NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 59.32

+2.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (323)	6/10/2010 11:29:15 AM
From: Arthur Radley	of 507

RK, I appreciate your skepticism....as you say the proof will be in the controlled Phase III. Haven't we all been burned by rat models and Phase II data! Ironically, NKTR's old next door neighbor burned me with such a few years back. Maybe as a lucky omen, NKTR is moving out of the complex while they have the money. With the demise of NUVO and with NKTR moving to the old PFE quarters......will leave a huge vacancy their on Hwy 101. On the positive side.....the CEO has cut some nice deals, and if he can do one for the cancer platform in the near future....that will be a real plus. Logic would be for PFE to cut them a deal---isn't it PFE old drug that they are using in this program. If I recall, PFE got it approved 15-20 years ago.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next